RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Greensboro, NC · Monroe, NC · Morehead City, NC · +56 more sites
Obesity clinical trials in Wilmington, NC
11 recruiting obesity studies with a site in Wilmington, NC.
RecruitingPhase 2NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Sponsor: Alveus Therapeutics, Inc.
Wilmington, NC · +19 more sites
RecruitingPhase 3NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Sponsor: Pfizer
Monroe, NC · Wilmington, NC · +14 more sites
RecruitingPhase 3NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Sponsor: Pfizer
Greensboro, NC · Wilmington, NC · +32 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Greensboro, NC · Monroe, NC · Morehead City, NC · +77 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Greensboro, NC · Greenville, NC · Morehead City, NC · +96 more sites
RecruitingPhase 3NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Chapel Hill, NC · Greensboro, NC · Wilmington, NC · +19 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Asheville, NC · Durham, NC · Lenoir, NC · +118 more sites
RecruitingPhase 3NCT07745504
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Sponsor: Novo Nordisk A/S
Greensboro, NC · Wilmington, NC · +9 more sites
RecruitingPhase 3NCT07654361
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Charlotte, NC · Durham, NC · Fayetteville, NC · +68 more sites
RecruitingPhase 3NCT07481630
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Sponsor: Novo Nordisk A/S
Wilmington, NC · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.